FDA approves Banner's application for generic Symmetrel

6/9/2008

HIGH POINT, N.C. Banner Pharmacaps announced June 2 that the Food and Drug Administration had approved its application for generic amantadine hydrochloride USP 100mg gelatin capsules four days before.

Amantadine (Symmetrel) is designed to prevent and treat signs and symptoms of respiratory tract infections resulting from various strains of influenza A virus. It also treats extra-pyramidal reactions related to Parkinson’s disease and drug reactions.

Banner Pharmacaps is a drug-delivery and specialty pharmaceutical company with headquarters in High Point, N.C. Its parent company is VION N.V., based in Son en Breugel, Netherlands.

X
This ad will auto-close in 10 seconds